GCG and Parkinson disease: In a PD mice model, orally administered engineered EcN delivered the heterologous GLP-1 to restore the disturbed microbiota by increasing the levels of beneficial Prevotella while suppressing the relative abundances of Akkermansia and Oscillospira, increasing intestinal vulnerability to oxidative stress [135].